DHL Supply Chain Spain – Francisco Milián, Chief Customer Officer &…
DHL Supply Chain has made great strides in recent years to invest in healthcare logistics in Spain. Francisco…
DHL Supply Chain Spain
Last updated: 15.10.2014
Providing life-saving products is a big responsibility, one with risks that far outweigh those in a typical supply chain environment. DHL understands the challenges facing life sciences companies. Together, we’ve created solutions that help you meet today’s challenges and anticipate tomorrow’s.
DHL’s customers include major pharmaceutical manufacturers and wholesalers, drug store groups, medical device manufacturers, health authorities, hospitals, health centers, hospital supply companies and other healthcare providers.
DHL’s disciplined processes, high quality standards and commitment to zero defects mean reliable, consistent services that ensure compliance with government agencies’ requirements.
CONTACT DETAILS
Calle de Rumanía, 1, 28821 Coslada, Madrid
TEL: +34 918 65 73 50
www.dhl.es
Interviews
Related
Spain / Entering the COVID-19 Vaccine Race Through Animal Health Champion
The Spanish pharma industry has entered the race to develop COVID-19 vaccines through an unexpected contender: an…
Spain / Grifols Invests in Nigerian Manufacturing; Almirall Nabs EMA Approval for AK Treatment; Zendal TB Vaccine Candidate Trials
The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP…
Spain / Market Growth; Esteve’s US Expansion; PTS Acquisition
The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle…
Spain / Grifols looks to Egypt; New Leadership Generation at Almirall; Ferrer’s EIB Loan; Esteve’s European Expansion
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
Spain / Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest…
COVID-19 / Spain’s PharmaMar to Begin Trials for Aplidin
PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat…
Report / New Spain Pharma Report September 2019 Out Now
Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences…
Juan Carlos Moro Rodríguez – CEO Iberia Cluster, DB Schenker
Juan Carlos Moro Rodríguez, CEO for the Iberia Cluster with DB Schenker, discusses the company’s plans to expand…
Company Profile / Jazz Pharmaceuticals Spain: Playing to a Different Beat
Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape,…
Specialising to Succeed in the Spanish Women’s Health Market
In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be…
Philanthropy / A Boost for Spain’s Out-of-Date Hospital Equipment
Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no…
Profile / Aspen Spain: Thriving on Change
The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia…
